Baxter International

American manufacturer of healthcare goods

BAX NYSE ISIN US0718131099 SEC CIK 10456
Follow Baxter International Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $3B +5% vs same quarter last year
Net income $294M +739.1% vs same quarter last year
EPS, diluted $0.57 +733.3% vs same quarter last year
Operating cash flow $558M +135.4% vs same quarter last year
Revenue by quarter
$2.8B
$2.6B
$2.8B
$2.8B
$3B
$2.7B
$3B
$3B
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$5B$0$5B$10B$15BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$11.2B−$957M
FY24$10.6B−$649M
FY23$10.4B$2.7B
FY22$10.1B−$2.4B
FY21$12.1B$1.3B
FY20$11.7B$1.1B
FY19$11.4B$1B
FY18$11.1B$1.5B
FY17$10.6B$602M
FY16$10.2B$5B
FY15$10B$968M
FY14$10.7B$2.5B
FY13$9.4B$2B
FY12$13.9B$2.3B
FY11$13.9B$2.2B
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−40%−20%0%20%40%60%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2530.1%−2.7%−8.5%
FY2437.5%0.1%−6.1%
FY2340.1%6.8%25.6%
FY2235.3%−28.3%−24.2%
FY2138.9%11.1%10.6%
FY2039.3%13.8%9.4%
FY1941.9%15.6%8.8%
FY1842.9%14.3%13.9%
FY1742.3%12.2%5.7%
FY1640.5%7.3%48.9%
FY1542%5.7%9.7%
FY1442.7%6.1%23.3%
FY1344.2%5.3%21.4%
FY1251.2%-16.7%
FY1150.7%-16%
Free cash flowOperating cash flow minus capital expenditure
$0$1B$2B$3BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$332M
FY24$573M
FY23$1.3B
FY22$834M
FY21$1.5B
FY20$1.2B
FY19$1.4B
FY18$1.4B
FY17$1.1B
FY16$935M
FY15$860M
FY14$2.3B
FY13$2.5B
FY12$1.9B
FY11$1.9B
Returned to shareholdersDividends paid and shares bought back
  • Dividends
  • Buybacks
$0$1B$2B$3BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearDividendsBuybacks
FY25$348M-
FY24$590M$0
FY23$586M$0
FY22$573M$32M
FY21$530M$600M
FY20$473M$500M
FY19$423M$1.3B
FY18$376M$2.5B
FY17$315M$564M
FY16$268M$292M
FY15$910M-
FY14$1.1B$550M
FY13$1B$913M
FY12$804M$1.5B
FY11$709M$1.6B
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Baxter International
  • Healthcare median
−100%−50%0%50%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearBaxter InternationalHealthcare median
FY25−8.5%−30.6%
FY24−6.1%−47%
FY2325.6%−58%
FY22−24.2%−80.4%
FY2110.6%−71.9%
FY209.4%−62.2%
FY198.8%−46.3%
FY1813.9%−49.6%
FY175.7%−45.9%
FY1648.9%−36%
FY159.7%−38.4%
FY1423.3%−35.5%
FY1321.4%−37.1%
FY1216.7%−29.1%
FY1116%−27.9%